Courtois cardiovascular signature program

Illustration: Dr. Matthias Friedrich and Dr.

Basic research in this program focuses on the study of biomarkers, histopathology, genetics, translational genomics and genetic epidemiology. Biomedical and clinical research is conducted in the domains of biodesign, health technology, regenerative medicine and information technology, with observational cardiovascular studies and clinical trials completed or underway. CHAL investigators with expertise in epidemiology conduct population health, outcomes and health services research. More selections: ; ; We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Courtois cardiovascular signature program

In ten years, Montreal will have the lowest hospitalization rate and fewest deaths due to heart disease in Canada. How will we achieve this? We and our partners use cookies to enhance your experience and understand how our digital platforms are used. For more information see our privacy policy. Foundation Foundation The Foundation. Our People. Foundation The Foundation. Our Actions. Our Reports. Impact Our Actions. Thank you for dreaming big with us. Give Once.

Read Our Inspiring Stories. We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

This is what we are attempting to discover, among other things, via this research. Our research is the first in the world to collect, capture and provide the research community with a valuable collection of data and information. Our year study will allow us to collect data on healthy volunteers, participants with cardiovascular risk factors and with known cardiovascular disease. Our efforts will allow us to personalize cardiovascular health in the future and tailor treatments to the unique combination of your genetic, microbiomic, environmental, and other factors that predispose to heart disease. Our program will help many people in the future. With the information collected, we will be able to understand what is a healthy heart, why some people develop heart disease when they appear otherwise healthy, and how we can identify the initial signs of heart disease, before they occur.

This is what we are attempting to discover, among other things, via this research. Our research is the first in the world to collect, capture and provide the research community with a valuable collection of data and information. Our year study will allow us to collect data on healthy volunteers, participants with cardiovascular risk factors and with known cardiovascular disease. Our efforts will allow us to personalize cardiovascular health in the future and tailor treatments to the unique combination of your genetic, microbiomic, environmental, and other factors that predispose to heart disease. Our program will help many people in the future. With the information collected, we will be able to understand what is a healthy heart, why some people develop heart disease when they appear otherwise healthy, and how we can identify the initial signs of heart disease, before they occur. Thanks to your donations, we will be able to continue our research, broaden our expertise and contribute to the advancement and knowledge of the research community. Donate and make a difference. What Defines a Healthy Heart?

Courtois cardiovascular signature program

There are steps you can do to stay healthy and prevent cardiovascular disease! Be active, eat healthy, manage your stress, and get regular check-ups. The more we learn about healthy hearts, the closer we will be to developing Precision Medicine, Preventing and fixing Broken Hearts! You or someone close to you may have experienced heart problems although no known risk factors were present. You can help us understand what is a healthy heart, why some individuals develop heart disease and others do not. The future of medicine, as we see it, is not to treat the average person; but to treat each person as a unique individual.

Mid length graduated bob hairstyles

Datasets Search Variables. The research team plans to enroll 4, participants, aged 35 to 79, one third of them healthy, one third considered at risk for heart disease, and one third with known heart disease. Name Louise Pilote Email louise. Data Collection Events. Sharon Steinberg. Information on cardiovascular events as well as change in medication use is collected. Illustration: Dr. Find an existing tribute page. Michael Tsoukas McGill University. Our year study will allow us to collect data on healthy volunteers, participants with cardiovascular risk factors and with known cardiovascular disease. Our locations. Do you want to make a difference and advance research on the heart? Co-led by Dr.

Matthias Friedrich and Dr. It will collect extensive amounts of genomic, microbiomic, imaging and lifestyle data, and use advanced machine learning to identify what part of their individual cardiovascular signature is linked to their good or poor health. In the context of this research initiative, a signature refers to the unique combination of a multitude of markers that may have an influence on the cardiovascular health of an individual.

Learn More. Name George Thanassoulis Email george. All participants will provide blood samples and undergo various tests, like an electrocardiogram and a walk test, as well as cardiac and cerebrovascular magnetic resonance imaging MRI. We and our partners use cookies to enhance your experience and understand how our digital platforms are used. Basic research in this program focuses on the study of biomarkers, histopathology, genetics, translational genomics and genetic epidemiology. Impact Our Actions. The data collected will be used to discover the unique profile of each participant — their cardiovascular signature. Our program will help many people in the future. Have a heart? Participating Studies. Work with Us. General Design. Biomedical and clinical research is conducted in the domains of biodesign, health technology, regenerative medicine and information technology, with observational cardiovascular studies and clinical trials completed or underway.